| Jessica Schleusner, DO | |
|
142 Wallace Ave Ste 201, Downingtown, PA 19335 | |
| (610) 269-7656 | |
| (610) 594-2625 |
| Full Name | Jessica Schleusner |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 142 Wallace Ave Ste 201, Downingtown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114363645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS017940 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Bayada Home Health Care, Inc. | Exton, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pentahealth, Llc | 9537586672 | 59 |
News Archive
Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (EIF's NCCRA) and the American Gastroenterological Association (AGA).
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.
Rates of C. difficile infections have decreased 36% in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ.
› Verified 8 days ago
| Entity Name | Gateway Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770659476 PECOS PAC ID: 5294707634 Enrollment ID: O20040806001106 |
News Archive
Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (EIF's NCCRA) and the American Gastroenterological Association (AGA).
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.
Rates of C. difficile infections have decreased 36% in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ.
› Verified 8 days ago
| Entity Name | Pentahealth, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639787740 PECOS PAC ID: 9537586672 Enrollment ID: O20200903000805 |
News Archive
Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (EIF's NCCRA) and the American Gastroenterological Association (AGA).
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.
Rates of C. difficile infections have decreased 36% in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Schleusner, DO 412 Creamery Way, Suite 400, Exton, PA 19341-2551 Ph: (610) 594-7590 | Jessica Schleusner, DO 142 Wallace Ave Ste 201, Downingtown, PA 19335 Ph: (610) 269-7656 |
News Archive
Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (EIF's NCCRA) and the American Gastroenterological Association (AGA).
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.
Rates of C. difficile infections have decreased 36% in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ.
› Verified 8 days ago
Laurie A Gallagher, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 142 Wallace Ave Ste 201, Downingtown, PA 19335 Phone: 610-873-2700 Fax: 610-594-2625 | |
Dr. Leonard Charles Giunta, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 797 E Lancaster Ave, Suite 17, Downingtown, PA 19335 Phone: 610-269-8155 Fax: 610-269-9557 | |
Dr. Shannon Kimberly Lieb, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 967 E Lancaster Ave, Downingtown, PA 19335 Phone: 484-593-5160 | |
Dr. Lawrence K Alwine, D O Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 77 Manor Ave, Suite 100, Downingtown, PA 19335 Phone: 610-269-9570 Fax: 610-269-3568 | |
Victoria Brosius Kollar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 142 Wallace Ave Ste 201, Downingtown, PA 19335 Phone: 610-873-2700 Fax: 610-594-2625 | |
Dr. Mary P Davis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2202 Potters Mill Cir, Downingtown, PA 19335 Phone: 515-371-9909 |